Home

News

Neurim Pharmaceuticals (1991) Ltd & Anr v Teva UK Ltd [2022] EWHC 954 (Pat)26 April 2022Charlotte May QC successfully appeared as lead counsel for the defendant (“Teva”) in opposing an application for an interim injunction brought by the claimants (“Neurim”) for an order restraining Teva from disposing of, offering for sale, selling or supplying a generic version of Circadin. The hearing of the application had been expedited by Roth J. […]
Alcon Eye Care UK Ltd & Anr v AMO Development LLC [2022] EWHC 955 (Pat)26 April 2022Michael Tappin QC and Henry Ward appeared for the defendant and patentee (“AMO”) in legal proceeding brought by the claimants (“Alcon”) to revoke two patents for ophthalmic surgical systems used for carrying out cataract surgery.  Alcon’s validity attack was based on obviousness and insufficiency.  AMO counterclaimed for infringement of the patents by Alcon’s LenSx laser […]
Lewis Silkin Podcast – FYIP: Diversity in the Legal Profession with 8 New Square’s Ashton Chantrielle21 April 2022This month, Stephanie Kay and Antony Craggs from Lewis Silkin interviewed Ashton Chantrielle.  Ashton discussed her process of becoming a Barrister and some of her recent cases, as well as diversity in the profession. Please click here to listen to the podcast.
easyGroup Ltd -v- Nuclei Ltd (t/a Easy Offices) & Ors [2022] EWHC 901 (Ch)13 April 2022Jaani Riordan successfully appeared as junior counsel led by Mark Vanhegan QC for the defendants (collectively, “Nuclei”) in proceedings brought by the claimant (“easyGroup”) alleging infringement of four EU and UK trade marks for EASYOFFICE in various forms (“the Trade Marks”).  The Trade Marks were registered in relation to services including hire and rental of […]
Sandoz Ltd & Ors v Bristol-Myers Squibb Holdings [2022] EWHC 822 (Pat)7 April 2022Michael Tappin QC appeared as lead counsel for Sandoz in proceedings brought with Teva to revoke a patent owned by Bristol-Myers Squibb (“BMS”).  BMS counterclaimed for infringement, which, in the event that the patent was found to be valid, Sandoz and Teva admitted. The patent related to the compound apixaban sold by BMS under the […]
Ed Sheeran -v- Chokri [2022] EWHC 827 (Ch)6 April 2022Jessie Bowhill acted for Ed Sheeran and others, the co-writers and publishers of the biggest selling song of 2017; “Shape of You”. In his Judgment of 6 April 2022 Zacaroli J held that they had not infringed any copyright of the Defendants in creating and exploiting that song.
CommScope Technologies LLC v SOLiD Technologies Inc [2022] EWHC 769 (Pat)1 April 2022James Abrahams QC appeared as lead counsel for the Claimant (“CommScope”) in proceedings brought against the Defendant (“SOLiD”) for patent infringement. The patents (“EP626” and “EP850”) related to distributed antenna systems (“DAS”) used in cellular wireless communications to distribute radio frequency signals transmitted from a base station into areas where the signal has been significantly […]
Neurim Pharmaceuticals (1991) Ltd & Anr v Generics UK Ltd & Anr [2022] EWCA Civ 35929 March 2022Andrew Lykiardopoulos QC appeared as lead counsel for the Claimants (“Neurim” and “Flynn” respectively) in an appeal against the orders of Marcus Smith J dated 30 December 2020 and 12 March 2021.  The Claimants alleged that the Defendants (“Mylan”) had infringed a second medical use patent claiming the prolonged release of melatonin for the purposes […]
Optis Cellular Technology LLC & Ors v Apple Retail UK Ltd & Ors [2022] EWHC 561 (Pat)15 March 2022James Whyte and Jennifer Dixon, led by Thomas Hinchliffe QC, appeared for the Claimants (“Optis”) and Charlotte May QC and Lindsay Lane QC appeared as lead counsel for the Defendants (“Apple”) in Trial D, the latest trial in the ongoing proceedings between these parties.  The wider proceedings relate to eight telecommunications patents owned by Optis […]
EP 14250043 of Valeda Co LLC, Opposition by Dahl Engineering AP11 March 2022Martin Howe QC appeared for the patentee Valeda Co LLC in opposition proceedings in the EPO, Munich, against the validity of EP 14250043 which related to restraints for wheelchairs in moving vehicles. The priority claimed by the European Patent was based on a US Provisional filing, which in error had named as applicant an individual […]